Ortho Tech is proud to announce that we have been appointed Malaysia's first 3shape TRIOS Ready laboratory
Ortho Tech is an official partner of the 3shape TRIOS Ready Program. We accept all TRIOS and other 3shape scans directly through TRIOS Inbox.
Ortho Tech is an official partner of the 3shape TRIOS Ready Orthodontics Program and can recieve all 3shape orthodontic cases through TRIOS Inbox.
The CE mark is a mandatory conformity marking for certain products sold within the European Economic Area (EEA) since 1985. The CE marking is the manufacturer's declaration that the product meets the requirements of the applicable EC directives.
TÜV SUD is a global provider of technical, safety, and certification services. The group's guiding principle is to achieve sustained development of safety and quality in order to meet the challenges arising from the interaction between man, technology and the environment.
The United States Department of Health and Human Services (HHS), also known as the Health Department, is a cabinet-level department of the U.S. federal government with the goal of protecting the health of all Americans and providing essential human services. Its motto is "Improving the health, safety, and well-being of America".
The KFDA is responsible for nearly every stage in the regulatory process. It establishes safety and quality standards for pharmaceuticals and medical devices, and it oversees the approval process to ensure that new pharmaceuticals and devices conform to their standards. In order to ensure compliance, the KFDA conducts scientific testing on products submitted for approval. The Drug Evaluation Department and Medical Device Evaluation Department operate within the respective drug and device bureaus to ensure quality and standardization.
The Therapeutic Goods Administration (TGA) is the regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia. The TGA is responsible for conducting assessment and monitoring activities to ensure that therapeutic goods available in Australia are of an acceptable standard and that access to therapeutic advances is in a timely manner.